BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 720058)

  • 1. No increase of the fibrinolytic activity of the human endometrium by progesterone-releasing IUD (ProgestasertR).
    Liedholm P; Sjöberg NO; Srivastava K; Astedt B
    Contraception; 1978 Jun; 17(6):531-6. PubMed ID: 720058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No increase of the fibrinolytic activity of the human endometrium by progesterone-releasing IUD (progestasertR).
    Liedholm P; Sjöberg NO; Srivastava K; Astedt B
    Contraception; 1978 Jun; 17(6):531-3. PubMed ID: 668372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in effect of copper and ProgestasertR IUDS on fibrinolytic activity of the endometrium in the rabbit.
    Liedholm P; Sjöberg NO
    Contraception; 1979 May; 19(5):443-8. PubMed ID: 467053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher fibrinolytic activity in human endometrium in direct contact with an IUD.
    Liedholm P; Srivastava K; Wingerup L; Astedt B
    Acta Obstet Gynecol Scand; 1983; 62(2):169-70. PubMed ID: 6868967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial morphological changes in IUD users: a review.
    Sheppard BL
    Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IUD-induced uterine bleeding.
    El-badrawi HH; Hafez ES
    Contracept Deliv Syst; 1980 Oct; 1(4):303-18. PubMed ID: 12262133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased fibrinolytic activity in the endometrium of patients using copper-IUD.
    Larsson B; Liedholm P; Sjöberg NO; Astedt B
    Contraception; 1974 May; 9(5):531-7. PubMed ID: 4448084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno and histochemical study of endometrium in women using copper IUCD.
    Mousa MA; El-mekkawi TM; Abdel Aziz AA; El-saharty MF
    Popul Sci; 1985; 6():41-50. PubMed ID: 12349093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
    Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
    Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinolytic activity in endometrium and uterine fluid of women using intrauterine contraceptive devices].
    Lu Q
    Shengzhi Yu Biyun; 1983 Aug; 3(3):6-8. PubMed ID: 12267402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histochemical changes in endometrial fibrolytic activity with different IUDs].
    Lu Q; Zheng XQ; Liu QX; Kong RZ; Feng HZ
    Shengzhi Yu Biyun; 1985 Feb; 5(1):24-8. PubMed ID: 12267332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic activity in bleeding associated with intrauterine contraceptive devices.
    Khanna A; Biswas AK; Dubey B; Khanna AK
    Indian J Med Res; 1992 Jun; 96():147-9. PubMed ID: 1512035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with the uterine progesterone system (Progestasert R).
    Zador G; Nilsson BA; Nilsson B; Sjöberg NO; Weström L; Wiese J
    Contraception; 1976 May; 13(5):559-69. PubMed ID: 1261259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
    Sheppard BL; Bonnar J
    Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of mast cells in the human endometrium pre- and post-insertion of intrauterine devices.
    Yin M; Zhu P; Luo H; Xu R
    Contraception; 1993 Sep; 48(3):245-54. PubMed ID: 8222654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative cytochemical study of ACP and AKP activity in the endometrial bleeding associated with copper intrauterine devices (IUDs)].
    Huang LL
    Shengzhi Yu Biyun; 1991 Aug; 11(3):22-6. PubMed ID: 12343702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.